M&A: Page 3
-
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
By Nick Paul Taylor • July 1, 2024 -
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
By Nick Paul Taylor • June 26, 2024 -
Boston Scientific buys Silk Road Medical for $1.26B
Silk Road developed a minimally invasive procedure to prevent stroke in patients with carotid artery disease.
By Susan Kelly • June 18, 2024 -
Illumina board approves Grail spinoff
Leerink Partners analyst Puneet Souda said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for years to come.”
By Susan Kelly • June 4, 2024 -
Stryker inks Artelon buyout to join Zimmer in soft tissue space
BTIG analysts said the takeover could serve as a "defensive mechanism against peers who have been growing rapidly in the space.”
By Nick Paul Taylor • June 4, 2024 -
BD to buy Edwards’ critical care unit for $4.2B
Edwards will sell the business rather than pursue its original strategy announced in December to spin off the group.
By Ricky Zipp • June 3, 2024 -
Medtech venture capital investing rebounded in Q1
Pitchbook analysts are cautiously optimistic that the funding pickup will continue despite uncertainty about interest rates, heightened regulatory scrutiny and the presidential election.
By Susan Kelly • June 3, 2024 -
Surmodics agrees to $627M private equity buyout
Surmodics will go private when the transaction closes, which is expected in the second half of the year.
By Ricky Zipp • May 31, 2024 -
Stereotaxis inks APT buyout to gain catheters for surgical robots
The partners are developing a robotically steered diagnostic catheter for use with Stereotaxis’ cardiovascular robots.
By Nick Paul Taylor • May 16, 2024 -
Samsung Medison to buy AI ultrasound company Sonio
Sonio’s software uses deep learning to improve image quality. Its software will remain compatible with all ultrasound machines, the company said.
By Elise Reuter • May 8, 2024 -
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
PathAI is selling its diagnostics assets, including a Tennessee laboratory, but will continue to support its biopharmaceutical customers.
By Nick Paul Taylor • May 2, 2024 -
Medline to buy Ecolab’s surgical products for nearly $1B
The medical products supplier will acquire Ecolab’s sterile drapes and fluid temperature management systems.
By Susan Kelly • May 1, 2024 -
Hologic to buy Endomagnetics for $310M
Endomagnetics, which makes guidance technology for breast cancer surgery, brought in about $35 million in revenue last year.
By Elise Reuter • April 30, 2024 -
Labcorp to acquire Invitae’s assets for $239M
William Blair analyst Andrew Brackmann said Labcorp is being aggressive in its M&A strategy, after announcing last month it would buy several of Bioreference Health’s testing businesses.
By Susan Kelly • April 25, 2024 -
Cancer test maker Dermtech to cut 100 jobs, explore strategic options
Dermtech, which will not hold a first-quarter earnings call, said the layoffs are part of a broader effort to “significantly reduce” expenses.
By Susan Kelly • April 19, 2024 -
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.”
By Nick Paul Taylor • April 19, 2024 -
Bruker to acquire Nanostring for $393M
Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.
By Susan Kelly • April 18, 2024 -
Steris to sell dental segment for $787.5M
Divesting the business will allow Steris to repay debt and focus on its core markets of healthcare, pharma and medtech.
By Elise Reuter • April 11, 2024 -
J&J to acquire Shockwave Medical for $13.1B
The deal comes just over a week after The Wall Street Journal reported that the companies were discussing a merger.
By Ricky Zipp • Updated April 5, 2024 -
FTC asks Boston Scientific for more info on $3.7B Axonics deal
The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.
By Susan Kelly • April 4, 2024 -
3M spins out Solventum
The new company will need to work through debt from the spinoff and sole-source arrangements with 3M.
By Elise Reuter • April 1, 2024 -
Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
The acquired assets generate about $100 million in annual revenue, according to the deal announcement.
By Nick Paul Taylor • March 29, 2024 -
J&J, Boston Scientific are top medtech spenders. But smaller deals fill 2024’s M&A list.
Boston Scientific recently closed two large acquisitions, buying Silk Road Medical and Axonics, while other firms made smaller, targeted purchases. Check out MedTech Dive’s roundup of M&A news.
By MedTech Dive staff • Updated Dec. 2, 2024 -
J&J in talks to buy Shockwave Medical: WSJ
The healthcare giant could follow up its $16.6 billion acquisition of Abiomed with another deal for a heart device company, the WSJ reported Tuesday.
By Ricky Zipp • March 27, 2024 -
Johnson Matthey to sell medical device components unit for $700M
The segment makes components for medical devices, such as nitinol and metallic coatings.
By Elise Reuter • March 20, 2024